Evaluation of external validity of the OVHIPEC-1 trial in a real-world population.

van Stein, Ruby M; Sikorska, Karolina; van der Aa, Maaike A; Sonke, Gabe S; van Driel, Willemien J

van Stein, Ruby M; Sikorska, Karolina; van der Aa, Maaike A; Sonke, Gabe S; van Driel, Willemien J.

Afiliação

van Stein RM; Department of Gynecologic Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
Sikorska K; Department of Biometrics, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van der Aa MA; Department of Research & Development, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands.
Sonke GS; Department of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
van Driel WJ; Department of Gynecologic Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.

Int J Gynaecol Obstet ; 161(2): 640-648, 2023 May.

Article em En | MEDLINE | ID: mdl-36495280

Assuntos

Hipertermia Induzida; Neoplasias Ovarianas; Feminino; Humanos; Neoplasias Ovarianas/patologia; Estudos de Coortes; Hipertermia Induzida/métodos; Carcinoma Epitelial do Ovário/terapia; Quimioterapia Intraperitoneal Hipertérmica; Terapia Combinada

Palavras-chave

HIPEC; OVHIPEC-1 trial; external validity; generalizability; ovarian cancer; overall survival

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Ovarianas / Hipertermia Induzida Tipo de estudo: Clinical_trials / Observational_studies / Prognostic_studies Limite: Female / Humans Idioma: En Revista: Int J Gynaecol Obstet Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google